Esra Dikoglu

2.9k total citations
14 papers, 402 citations indexed

About

Esra Dikoglu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Esra Dikoglu has authored 14 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Esra Dikoglu's work include Cancer Genomics and Diagnostics (4 papers), RNA regulation and disease (3 papers) and Genomics and Rare Diseases (2 papers). Esra Dikoglu is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), RNA regulation and disease (3 papers) and Genomics and Rare Diseases (2 papers). Esra Dikoglu collaborates with scholars based in United States, Switzerland and Türkiye. Esra Dikoglu's co-authors include Belinda Campos‐Xavier, Sheila Unger, Vaidehi Jobanputra, Andrea Superti‐Furga, Luisa Bonafé, Tae‐Joon Cho, Jong‐Hee Chae, Giulio Superti‐Furga, Maha S. Zaki and Kazimierz O. Wrzeszczyński and has published in prestigious journals such as Annals of Neurology, Scientific Reports and Nature Protocols.

In The Last Decade

Esra Dikoglu

13 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esra Dikoglu United States 10 232 111 80 75 70 14 402
Audrey Y. Frist United States 10 313 1.3× 67 0.6× 70 0.9× 122 1.6× 32 0.5× 14 495
Xiaoli Xu China 11 262 1.1× 89 0.8× 22 0.3× 38 0.5× 84 1.2× 20 385
Jyotidarsini Mohanty United States 7 287 1.2× 86 0.8× 75 0.9× 19 0.3× 36 0.5× 10 421
Thomas Hoelting Germany 14 145 0.6× 109 1.0× 78 1.0× 130 1.7× 44 0.6× 21 460
Sara Jaber France 11 221 1.0× 128 1.2× 21 0.3× 40 0.5× 52 0.7× 18 401
HyoungBin Oh United States 6 271 1.2× 66 0.6× 96 1.2× 65 0.9× 58 0.8× 7 435
Janet Y. Leung United States 7 376 1.6× 56 0.5× 57 0.7× 31 0.4× 27 0.4× 9 480
Priyanka Tibarewal United Kingdom 7 425 1.8× 72 0.6× 22 0.3× 94 1.3× 71 1.0× 11 486
Nicola Modena Italy 4 375 1.6× 128 1.2× 51 0.6× 21 0.3× 57 0.8× 5 470
Gregory Miles United States 5 199 0.9× 88 0.8× 46 0.6× 28 0.4× 117 1.7× 5 345

Countries citing papers authored by Esra Dikoglu

Since Specialization
Citations

This map shows the geographic impact of Esra Dikoglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Dikoglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Dikoglu more than expected).

Fields of papers citing papers by Esra Dikoglu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esra Dikoglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Dikoglu. The network helps show where Esra Dikoglu may publish in the future.

Co-authorship network of co-authors of Esra Dikoglu

This figure shows the co-authorship network connecting the top 25 collaborators of Esra Dikoglu. A scholar is included among the top collaborators of Esra Dikoglu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esra Dikoglu. Esra Dikoglu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Abuhadra, Nour, Fresia Pareja, Hannah Y. Wen, et al.. (2025). Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer. npj Breast Cancer. 11(1). 110–110.
2.
Dikoglu, Esra & Fresia Pareja. (2025). Molecular Basis of Breast Tumor Heterogeneity. Advances in experimental medicine and biology. 1464. 237–257. 1 indexed citations
3.
Cabel, Luc, David M. Kurtz, Daniel W. Ross, et al.. (2024). 293P Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq. Annals of Oncology. 35. S338–S338. 1 indexed citations
4.
Welch, James, Sriram Gubbi, Sudheer Kumar Gara, et al.. (2021). Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors—A Cohort Study. Frontiers in Endocrinology. 12. 653401–653401. 4 indexed citations
5.
Wrzeszczyński, Kazimierz O., Sadia Rahman, Mayu O. Frank, et al.. (2019). Identification of targetable BRAF ΔN486_P490 variant by whole-genome sequencing leading to dabrafenib-induced remission of a BRAF-mutant pancreatic adenocarcinoma. Molecular Case Studies. 5(6). a004424–a004424. 19 indexed citations
6.
Rosti, Rasim Özgür, Esra Dikoglu, Maha S. Zaki, et al.. (2016). Extending the mutation spectrum for Galloway–Mowat syndrome to include homozygous missense mutations in the WDR73 gene. American Journal of Medical Genetics Part A. 170(4). 992–998. 26 indexed citations
7.
Fang, Han, Ewa A. Bergmann, Kanika Arora, et al.. (2016). Indel variant analysis of short-read sequencing data with Scalpel. Nature Protocols. 11(12). 2529–2548. 77 indexed citations
8.
Jerber, Julie, Maha S. Zaki, Jumana Y. Al‐Aama, et al.. (2016). Biallelic Mutations in TMTC3, Encoding a Transmembrane and TPR-Containing Protein, Lead to Cobblestone Lissencephaly. The American Journal of Human Genetics. 99(5). 1181–1189. 33 indexed citations
9.
Baştürk, Olca, Marcus Tan, Umesh Bhanot, et al.. (2016). The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes. Modern Pathology. 29(9). 1058–1069. 68 indexed citations
10.
Zaki, Maha S., Tipu Sultan, Mahmoud Y. Issa, et al.. (2016). PYCR2Mutations cause a lethal syndrome of microcephaly and failure to thrive. Annals of Neurology. 80(1). 59–70. 30 indexed citations
11.
Dikoglu, Esra, Ali Abdullah Alfaiz, Maria W. Górna, et al.. (2015). Mutations in LONP1, a mitochondrial matrix protease, cause CODAS syndrome. American Journal of Medical Genetics Part A. 167(7). 1501–1509. 60 indexed citations
12.
Royer‐Bertrand, Béryl, Tae‐Joon Cho, Jong‐Hee Chae, et al.. (2015). Mutations in the heat-shock protein A9 (HSPA9) gene cause the EVEN-PLUS syndrome of congenital malformations and skeletal dysplasia. Scientific Reports. 5(1). 17154–17154. 53 indexed citations
13.
Şimşek‐Kiper, Pelin Özlem, Esra Dikoglu, Belinda Campos‐Xavier, et al.. (2014). Positive effects of an angiotensin II type 1 receptor antagonist in Camurati–Engelmann disease: A single case observation. American Journal of Medical Genetics Part A. 164(10). 2667–2671. 19 indexed citations
14.
Dikoglu, Esra, Pelin Özlem Şimşek‐Kiper, Gülen Eda Ütine, et al.. (2013). Homozygosity for a novel truncating mutation confirms TBX15 deficiency as the cause of Cousin syndrome. American Journal of Medical Genetics Part A. 161(12). 3161–3165. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026